Silgan (NYSE:SLGN) Announces Quarterly Earnings Results

Silgan (NYSE:SLGN) posted its quarterly earnings results on Wednesday. The industrial products company reported $0.67 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.65 by $0.02, Briefing.com reports. The business had revenue of $1.47 billion during the quarter, compared to analysts’ expectations of $1.46 billion. Silgan had a net margin of 4.91% and a return on equity of 19.47%. The business’s quarterly revenue was up 4.1% on a year-over-year basis. During the same quarter last year, the company posted $0.85 earnings per share.

Here are the key takeaways from Silgan’s conference call:

• Silgan completed the Weener acquisition integration and achieved run‑rate synergies, with Dispensing & Specialty Closures now >50% of Adjusted EBITDA and delivering record sales, adjusted EBIT/EBITDA while accelerating its new‑product pipeline and wins.
• For 2026 management targets Adjusted EPS of $3.70–$3.90, expects roughly $450 million of free cash flow and will spend about $310 million of CapEx to support dispensing and pet‑food growth, with midpoint guidance exceeding 2025 Adjusted EBIT/EBITDA.
• Interest costs will increase materially (estimated ~$205 million for 2026 and roughly $45 million in Q1) due to the April maturity of the 1.4% senior secured notes, which pressured Q4 adjusted EPS and will weigh on net income and cash flow in 2026.
• Metal Containers showed volume growth (+4% quarterly, pet food +7%) and margin improvement driven by cost‑reduction programs and volume leverage, and management expects low single‑digit volume and adjusted EBIT growth in 2026, led by pet food.
• Although Dispensing & Specialty Closures destocking is reported complete, Custom Containers still carries some destocking and inventory timing effects (plus prior‑quarter pre‑buys), contributing to a Q1 adjusted EPS guide of $0.70–$0.80 versus $0.82 a year ago.

Silgan Price Performance

Shares of Silgan stock traded up $3.24 on Wednesday, hitting $47.00. The company’s stock had a trading volume of 116,942 shares, compared to its average volume of 829,401. The company has a market capitalization of $4.97 billion, a price-to-earnings ratio of 15.97, a price-to-earnings-growth ratio of 1.92 and a beta of 0.72. Silgan has a 1 year low of $36.15 and a 1 year high of $57.04. The company has a debt-to-equity ratio of 1.68, a quick ratio of 0.85 and a current ratio of 1.27. The firm has a fifty day moving average price of $41.18 and a 200-day moving average price of $43.09.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on SLGN. Wells Fargo & Company reduced their price target on shares of Silgan from $55.00 to $52.00 and set an “overweight” rating for the company in a research report on Thursday, October 30th. Weiss Ratings reissued a “hold (c-)” rating on shares of Silgan in a report on Monday, December 29th. Zacks Research raised shares of Silgan from a “strong sell” rating to a “hold” rating in a report on Monday, December 29th. Raymond James Financial reiterated a “market perform” rating on shares of Silgan in a research note on Thursday, January 15th. Finally, Truist Financial set a $50.00 target price on Silgan and gave the stock a “buy” rating in a research note on Tuesday, January 6th. Five investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $50.38.

Insider Buying and Selling

In other Silgan news, CAO Kimberly Irene Ulmer acquired 1,000 shares of the business’s stock in a transaction dated Friday, November 7th. The stock was acquired at an average cost of $38.11 per share, for a total transaction of $38,110.00. Following the completion of the transaction, the chief accounting officer directly owned 105,321 shares of the company’s stock, valued at $4,013,783.31. This represents a 0.96% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.13% of the company’s stock.

Institutional Investors Weigh In On Silgan

A number of institutional investors have recently added to or reduced their stakes in SLGN. Tower Research Capital LLC TRC increased its stake in Silgan by 79.3% during the 2nd quarter. Tower Research Capital LLC TRC now owns 7,403 shares of the industrial products company’s stock worth $401,000 after buying an additional 3,275 shares in the last quarter. Vident Advisory LLC boosted its stake in shares of Silgan by 19.4% in the second quarter. Vident Advisory LLC now owns 6,416 shares of the industrial products company’s stock worth $348,000 after acquiring an additional 1,043 shares during the last quarter. NewEdge Advisors LLC increased its position in shares of Silgan by 4.8% during the second quarter. NewEdge Advisors LLC now owns 6,767 shares of the industrial products company’s stock worth $367,000 after purchasing an additional 308 shares in the last quarter. Bank of Nova Scotia raised its stake in Silgan by 41.8% in the 2nd quarter. Bank of Nova Scotia now owns 6,967 shares of the industrial products company’s stock valued at $377,000 after purchasing an additional 2,055 shares during the last quarter. Finally, Creative Planning lifted its holdings in Silgan by 13.5% in the 2nd quarter. Creative Planning now owns 4,500 shares of the industrial products company’s stock valued at $244,000 after purchasing an additional 536 shares in the last quarter. Institutional investors and hedge funds own 70.25% of the company’s stock.

Silgan Company Profile

Silgan Holdings Inc (NYSE: SLGN) is a leading supplier of rigid packaging solutions for consumer goods manufacturers. The company’s core business activities center on the design, production and distribution of metal and plastic containers, closures and dispense systems. Silgan serves a broad array of end markets, including food and beverage, home and personal care, health care and industrial products, providing both standard and custom packaging formats.

Founded in 1987 and headquartered in Stamford, Connecticut, Silgan has grown organically and through strategic acquisitions to establish a global manufacturing footprint.